Livoluk Pantea Biotec medicine for constipation, prevention of hepatic cerebral disease (100 ml)

Dosage form Solution
Specifications Box
Ingredient Lactulose

Ingredient

Thành phần cho 15ml

Composition information	Content
Lactulose	10g

Uses

indications

Livoluk drug is indicated in the following cases:

Treatment of chronic constipation. After reaching the colon, lactulose is converted by intestinal bacteria into low molecular acids (lactic acid, formic acid, acetic acid) and carbon dioxid. These products increase osmotic pressure and increase acidity in the intestinal environment, resulting in increased water in feces, softening stool. Moreover, because the intestinal environment is more acidic in blood, ammonia can diffuse from blood into the intestine. The acidic medium in the intestinally transferred ammonia (NH3) into ammonium ionic (NH4+) cannot be diffused from the intestine into the bloodstream. The laxative effect of Lactulose helps remove ammonium ions (NH4) from the body faster. As a result, the content of ammonia in the blood decreases.

Pharmacokinetics

absorption

Lactulose is almost unprocessed in the gastrointestinal tract. Drugs to the large intestine, mainly in the form of metabolic.

Metabolism

The drug is metabolized by bacteria, forming organic acids such as lactic acid and acetic acid.

Elimination

Lactulose is excreted in the urine in the form of not metabolized about 3% or less. Eliminating drugs mainly in feces.

Before taking Livoluk Pantea Biotec medicine for constipation, prevention of hepatic cerebral disease (100 ml)

How to use

can drink lactulose solution with water or juice if necessary. Each dose of lactulose should be taken once and avoided in the mouth for too long. In treatment with laxatives, you should drink enough water (1.5 - 2 liters, equivalent to 6-8 glasses) during the day.

Dosage

constipation

Adults and children over 10 years old: starting at 15 ml, 2 times/day.

Children 5 - 10 years old: 10 ml, 2 times/day.

Children under 5 years old: 5 ml, 2 times/day.

Children under 1 year of age: 2.5 ml - 5 ml per day.

All doses later should be adjusted depending on the needs of each individual. The starting dose can be adjusted after the full therapy effect.

Prevention of liver disease

Adults: Start 30 - 50 ml (6 - 10 tablespoons 5 ml), 3 times/day. Then adjust the dose to be able to defecate 2 or 3 times daily.

Children: There is no recommended dose for this object.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

Symptoms:

diarrhea and abdominal pain, dehydration, hypotension, hypotension.

Treatment:

There is no specific antidote, mainly stopping medication and symptomatic treatment.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Livoluk, you may experience unwanted effects (ADR).

Common, ADR> 1/100

Digestive: flatulence, diarrhea.

Uncommon, 1/1000

Digestive: abdominal pain, nausea, vomiting.

electrolyte: Hydropic hyperkemis.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Livoluk drugs contraindicated in the following cases:

Contraindicated in patients with blood galactose or lactose abstinence, patients with stomach - intestinal obstruction.

Sensitive to any ingredients of the drug.

Be cautious when using

lactulose should be carefully indicated for patients without lactose intolerance. Lactulose solution contains galactose (less than 1.6 g/15 ml) and lactose (less than 1.2 g/15 ml), thus should be used carefully in diabetics. Be careful when using laxatives in children due to the risk of losing reflexes in bridges in children.

The ability to drive and operate machinery

does not affect.

Pregnancy

The study was conducted in rats and rabbits with a dose of up to 2 or 4 times orally in humans, showing no evidence of fertility or damage to the fetus by lactulose. However, there is no adequate and controlled research in pregnant women. Because animal studies do not always properly guess the reactions on humans, this drug should only be used during pregnancy when really necessary.

The period of breastfeeding

whether the drug is excreted through breast milk or not is not known. Because there are many drugs excreted through breast milk, it is necessary to be cautious when using Lactulose solution for nursing women.

Drug interaction

There have been conflict reports on simultaneous use of Neomycin and Lactulose solution. Theoretically, the removal of some intestinal bacteria by Neomycin and other antibiotics may affect the metabolism of lactulose and thus prevent acidification in the intestinal environment. Therefore, the patient is treated at the same time Lactulose with oral antibiotics should be closely monitored.

Preliminary research results in humans and mice show that simultaneous use of lactulose with non -absorbing antacids can affect the purpose of reducing its bowel pH. Therefore, it is necessary to consider the effectiveness of the treatment of antacids before being used with lactulose.

Not used simultaneously with other laxatives, especially in the early stages of the treatment of hepatic brain disease due to causing a lot of defecation, making it difficult to accurately determine the lactulose dose.

Storage

Store less than 30 ° C, cool dry place, avoid light.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.